Find uplifting stories about heroes, innovations, and solutions
18 results for "psilocybin"
New research shows that a single dose of psilocybin combined with therapy helped smokers quit at six times the rate of traditional nicotine patches. After decades without new smoking cessation tools, this breakthrough could offer hope to millions trying to kick the habit.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
Virginia lawmakers just passed groundbreaking legislation to help veterans struggling with depression and PTSD. Once the FDA approves psilocybin-based medicine, veterans will have immediate legal access to this promising treatment.
A new executive order cuts red tape for scientists studying psychedelic compounds like MDMA and psilocybin as treatments for depression, PTSD, and addiction. The breakthrough also includes $50 million for research into ibogaine, a powerful substance showing promise for opioid addiction.
President Trump will sign an executive order Saturday to advance research into psychedelics like psilocybin and ibogaine for therapeutic use. The move could open doors for controlled access to these promising mental health treatments.
Researchers analyzed over 500 brain scans and discovered a common "neural fingerprint" across LSD, psilocybin, and three other psychedelics. This breakthrough could strengthen clinical trials testing these substances for depression and PTSD.
University of South Florida researchers are running clinical trials using psilocybin to help people with serious mental health conditions. The studies could open new treatment paths for patients who haven't found relief through traditional therapies.
A Colorado woman battling stage III uterine cancer joined a groundbreaking study combining psilocybin with therapy to treat anxiety and depression. The results transformed how she lives with her diagnosis.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. Even the researchers were stunned by how powerful the results turned out to be.
New Mexico just set aside $630,000 to ensure low-income and rural residents can access groundbreaking psilocybin therapy for treatment-resistant depression and PTSD. The state is creating the nation's first medically integrated psilocybin program, launching by end of 2026.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. It's the first potential new smoking cessation medication in 20 years.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
A groundbreaking psilocybin-based therapy just moved closer to becoming the first psychedelic treatment approved for severe depression. Two major clinical trials showed the therapy significantly improved symptoms with just one or two doses.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
A psychedelic treatment could soon offer new hope for people with severe depression who haven't found relief from traditional medicines. Two major clinical trials show the psilocybin therapy helped patients improve more than standard care.
New research shows psychedelics like psilocybin and MDMA could help people with PTSD recover in hours instead of months by actually rewiring trauma-affected brain systems. Clinical trials reveal 67% of patients no longer met PTSD criteria after MDMA-assisted therapy, offering hope to 12 million Americans struggling with the condition.
A Queensland clinic is transforming mental health treatment by scanning brains first, then targeting therapy with magnetic fields, ketamine, and psilocybin. Patients who suffered for decades are sleeping through the night and living without pain for the first time.